Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Hypertension (Dallas, Tex. : 1979)|June 7, 2017
Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D MutationGeok Chin Tan, Giulia Negro, Alexandra Pinggera, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 4, 2020
Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IVChristos Reppas, Napoleon-Nikolaos Vrettos, Jennifer Dressman, et al.
Frontiers in Cardiovascular Medicine|March 20, 2023
A new integrative approach to assess aortic stenosis burden and predict objective functional improvement after TAVRJose M de la Torre Hernandez, Gabriela Veiga Fernandez, Eyal Ben-Assa, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
The extracellular vesicle transcriptome provides tissue-specific functional genomic annotation relevant to disease susceptibility in obesityEmeli Chatterjee, Michael J Betti, Quanhu Sheng, et al.
Cell Genomics|July 16, 2025
The extracellular vesicle transcriptome provides tissue-specific functional genomic annotation relevant to disease susceptibility in obesityEmeli Chatterjee, Michael J Betti, Quanhu Sheng, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Nature|September 6, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionPetra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 4, 2016
IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classesAdam S Darwich, Alison Margolskee, Xavier Pepin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 7, 2016
IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of resultsAlison Margolskee, Adam S Darwich, Xavier Pepin, et al.
Pageof 10